Sky Oak Wealth, LLC Gritstone Bio, Inc. Transaction History

Sky Oak Wealth, LLC

  • $445 Million
  • Q3 2024

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024
SELL
$0.62 - $2.35 $10,429 - $39,529
-16,821 Reduced 53.67%
14,520 $9,000
Q1 2024

Apr 29, 2024
SELL
$1.96 - $2.9 $10,386 - $15,367
-5,299 Reduced 14.46%
31,341 $80,000
Q4 2023

Jan 12, 2024
SELL
$1.28 - $2.85 $31,020 - $69,069
-24,235 Reduced 39.81%
36,640 $74,000
Q3 2023

Oct 24, 2023
SELL
$1.19 - $2.26 $15,969 - $30,329
-13,420 Reduced 18.06%
60,875 $104,000
Q2 2023

Jul 20, 2023
SELL
$1.66 - $3.03 $87,005 - $158,811
-52,413 Reduced 41.37%
74,295 $144,000
Q1 2023

May 02, 2023
SELL
$2.13 - $3.74 $5,495 - $9,649
-2,580 Reduced 2.0%
126,708 $352,000
Q4 2022

Jan 26, 2023
SELL
$2.17 - $3.92 $7,731 - $13,966
-3,563 Reduced 2.68%
129,288 $0
Q2 2022

Jul 26, 2022
SELL
$1.77 - $4.34 $65,286 - $160,080
-36,885 Reduced 21.73%
132,851 $321,000
Q1 2022

Apr 18, 2022
BUY
$4.03 - $12.19 $576,918 - $1.75 Million
143,156 Added 538.59%
169,736 $699,000
Q4 2021

Jan 24, 2022
BUY
$8.76 - $13.71 $490 - $767
56 Added 0.21%
26,580 $342,000
Q2 2021

Jul 19, 2021
SELL
$8.13 - $10.2 $7,227 - $9,067
-889 Reduced 3.24%
26,524 $242,000
Q1 2021

Apr 29, 2021
SELL
$4.07 - $27.11 $172,425 - $1.15 Million
-42,365 Reduced 60.71%
27,413 $268,000
Q4 2020

Feb 02, 2021
BUY
$2.57 - $4.22 $179,329 - $294,463
69,778 New
69,778 $275,000

Others Institutions Holding GRTS

# of Institutions
62
Shares Held
35.4M
Call Options Held
395K
Put Options Held
132K
View Full List

About Gritstone bio, Inc.

GRTS Quotes by TradingView
  • Ticker GRTS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,006,896
  • Market Cap $2.19M
  • Description
  • Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...
More about GRTS
Track This Portfolio

Track Sky Oak Wealth, LLC Portfolio

Follow Sky Oak Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sky Oak Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sky Oak Wealth, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email